ArticlePLoS pathogens2013
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.
Frederic Vigant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this paperpooled itcites it